November 14, 2012

Sanofi Appoints Dr. Gary J. Nabel as Chief Scientific Officer

 

Sanofi Appoints Dr. Gary J. Nabel as Chief Scientific Officer

Paris, France – November 14, 2012 – Sanofi (EURONEXT : SAN ; NYSE : SNY) is pleased to announce today the appointment of Dr. Gary J. Nabel, M.D., Ph.D., Senior Vice President, Chief Scientific Officer and Deputy to the President for Global R&D, effective December 3, 2012. Dr. Nabel will report to Dr. Elias Zerhouni, President, Global R&D, and will join the group’s Global Leadership Team. He will be based in Cambridge, Massachusetts.